Healthcare generates 4.4% of global greenhouse gas emissions, making end‑to‑end sustainability in pharma non‑negotiable.

This white paper shows how pharma leaders and logistics partners can embed Environmental, Social, and Governance (ESG) into sourcing, manufacturing, packaging, and distribution to cut Scope 3 emissions. From biofuels and sustainable aviation fuel to circular packaging, advanced emissions measurement, and cross-functional governance, it highlights practical moves you can deploy now.

Download the white paper to see how integrated ESG strategies can turn your pharma logistics network into a competitive, future‑ready asset.

Key Insights

• Why Scope 3 emissions are pharma’s biggest decarbonization lever
• How integrated logistics strategies accelerate measurable Greenhouse Gas (GHG) reduction
• The operational impact of biofuels, sustainable aviation fuel (SAF), and modal optimization
• Why circular packaging demands a lifecycle, not siloed, approach
• The governance and cross‑functional leadership needed to move from ESG ambition to execution